LAKE FOREST, Ill. , Nov. 26, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the 31 st Annual Piper Jaffray Healthcare Conference in a session scheduled for 9:30 a.m.

LAKE FOREST, Ill. , Nov. 13, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the Stifel Healthcare Conference in a session scheduled for 10:20 a.m. ET , Wednesday, November 20, 2019 in New York, NY.

-- Company Implements New Cost Savings Initiatives Expected to Deliver Annualized Savings of $20.0 Million -- -- Raises Full-Year 2019 Earnings Guidance Ranges -- -- Lowers Full-Year 2019 Neurology Franchise Net Sales Guidance -- -- Reduces Total Debt by $200.0 Million Year to Date --  -- Extends

LAKE FOREST, Ill. , Oct. 23, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that it will release third-quarter 2019 financial results on Wednesday, November 6, 2019 , after the close of markets. Following the announcement, the Company will host a conference call

LAKE FOREST, Ill. , Oct. 21, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), today announced that its development partner West Therapeutic Development, LLC (West) has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration ( FDA ) for its New Drug

LAKE FOREST, Ill. , Sept. 30, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) announced today that Dr. David Wheadon has been appointed to the Company’s Board of Directors. Dr. Wheadon is a former senior executive of AstraZeneca plc .

LAKE FOREST, Ill. , Sept. 26, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the Annual Cantor Fitzgerald Global Healthcare Conference in a session scheduled for 12:35 p.m.

LAKE FOREST, Illinois , Aug. 20, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the 17 th Annual Morgan Stanley Global Healthcare Conference in a session scheduled for 11:45 a.m.

LAKE FOREST, Ill. , Aug. 09, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) (“Assertio”) today announced it has entered into separate, privately negotiated exchange agreements (the “Exchange Agreements”) with a limited number of holders of Assertio’s currently outstanding 2.50%

-- Reports Total Company GAAP Net Sales of $57.2 million , Total Company Non-GAAP Net Sales of $59.3 million , including Commercialization Agreement Revenues of $31.0 million -- -- Drives Continued Improvement in Operating Efficiencies as the Company  Executes on its Ongoing Transformation -- --